BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35105451)

  • 1. The emerging importance and evolving understanding of clonal hematopoiesis in multiple myeloma.
    DeStefano CB; Gibson SJ; Sperling AS; Richardson PG; Ghobrial I; Mo CC
    Semin Oncol; 2022 Feb; 49(1):19-26. PubMed ID: 35105451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How predictive is the finding of clonal hematopoiesis for the development of myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML)?
    Steensma DP
    Best Pract Res Clin Haematol; 2021 Dec; 34(4):101327. PubMed ID: 34865699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid neoplasms secondary to plasma cell myeloma: an intrinsic predisposition or therapy-related phenomenon? A clinicopathologic study of 41 cases and correlation of cytogenetic features with treatment regimens.
    Reddi DM; Lu CM; Fedoriw G; Liu YC; Wang FF; Ely S; Boswell EL; Louissaint A; Arcasoy MO; Goodman BK; Wang E
    Am J Clin Pathol; 2012 Dec; 138(6):855-66. PubMed ID: 23161720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cumulative exposure to melphalan chemotherapy and subsequent risk of developing acute myeloid leukemia and myelodysplastic syndromes in patients with multiple myeloma.
    Jonsdottir G; Björkholm M; Turesson I; Hultcrantz M; Diamond B; Porwit A; Landgren O; Kristinsson SY
    Eur J Haematol; 2021 Aug; 107(2):275-282. PubMed ID: 33966293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal hematopoiesis and preleukemia-Genetics, biology, and clinical implications.
    Hartmann L; Metzeler KH
    Genes Chromosomes Cancer; 2019 Dec; 58(12):828-838. PubMed ID: 30939217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal Hematopoiesis and therapy related MDS/AML.
    Desai P; Roboz GJ
    Best Pract Res Clin Haematol; 2019 Mar; 32(1):13-23. PubMed ID: 30927970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS).
    Mailankody S; Pfeiffer RM; Kristinsson SY; Korde N; Bjorkholm M; Goldin LR; Turesson I; Landgren O
    Blood; 2011 Oct; 118(15):4086-92. PubMed ID: 21795746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and Genomic Landscape of Secondary and Therapy-Related Acute Myeloid Leukemia.
    Higgins A; Shah MV
    Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32640569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor clonal hematopoiesis increases risk of acute graft versus host disease after matched sibling transplantation.
    Oran B; Champlin RE; Wang F; Tanaka T; Saliba RM; Al-Atrash G; Garcia-Manero G; Kantarjian H; Cao K; Shpall EJ; Alousi AM; Mehta RS; Popat U; Futreal A; Takahashi K
    Leukemia; 2022 Jan; 36(1):257-262. PubMed ID: 34135465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early detection and intervention of clonal hematopoiesis for preventing hematological malignancies.
    Ye B; Sheng Y; Zhang M; Hu Y; Huang H
    Cancer Lett; 2022 Jul; 538():215691. PubMed ID: 35469959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and Pathogenesis of Myelodysplastic Syndrome.
    Rotter LK; Shimony S; Ling K; Chen E; Shallis RM; Zeidan AM; Stahl M
    Cancer J; 2023 May-Jun 01; 29(3):111-121. PubMed ID: 37195766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological and clinical significance of dysplastic hematopoiesis in patients with newly diagnosed multiple myeloma.
    Maia C; Puig N; Cedena MT; Goicoechea I; Valdes-Mas R; Vazquez I; Chillon MC; Aguirre P; Sarvide S; Gracia-Aznárez FJ; Alkorta G; Calasanz MJ; Garcia-Sanz R; Gonzalez M; Gutierrez NC; Martinez-Lopez J; Perez JJ; Merino J; Moreno C; Burgos L; Alignani D; Botta C; Prosper F; Matarraz S; Orfao A; Oriol A; Teruel AI; de Paz R; de Arriba F; Hernandez MT; Palomera L; Martinez R; Rosiñol L; Mateos MV; Lahuerta JJ; Blade J; San Miguel JF; Paiva B
    Blood; 2020 Jun; 135(26):2375-2387. PubMed ID: 32299093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy-related myeloid neoplasms after treatment for plasma-cell disorders.
    Chung A; Liedtke M
    Best Pract Res Clin Haematol; 2019 Mar; 32(1):54-64. PubMed ID: 30927976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute myeloid leukemia derived from lympho-myeloid clonal hematopoiesis.
    Thol F; Klesse S; Köhler L; Gabdoulline R; Kloos A; Liebich A; Wichmann M; Chaturvedi A; Fabisch J; Gaidzik VI; Paschka P; Bullinger L; Bug G; Serve H; Göhring G; Schlegelberger B; Lübbert M; Kirchner H; Wattad M; Kraemer D; Hertenstein B; Heil G; Fiedler W; Krauter J; Schlenk RF; Döhner K; Döhner H; Ganser A; Heuser M
    Leukemia; 2017 Jun; 31(6):1286-1295. PubMed ID: 27881874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study.
    Steensma DP; Abedi M; Bejar R; Cogle CR; Foucar K; Garcia-Manero G; George TI; Grinblatt D; Komrokji R; Ma X; Maciejewski J; Pollyea DA; Savona MR; Scott B; Sekeres MA; Thompson MA; Swern AS; Nifenecker M; Sugrue MM; Erba H
    BMC Cancer; 2016 Aug; 16():652. PubMed ID: 27538433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute myeloid leukemia or myelodysplastic syndrome with chromosome 17 abnormalities and long-term outcomes with or without hematopoietic stem cell transplantation.
    Britt A; Mohyuddin GR; McClune B; Singh A; Lin T; Ganguly S; Abhyankar S; Shune L; McGuirk J; Skikne B; Godwin A; Pessetto Z; Golem S; Divine C; Dias A
    Leuk Res; 2020 Aug; 95():106402. PubMed ID: 32590108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Impacts of new agents for multiple myeloma on development of secondary myelodysplastic syndrome and acute myeloid leukemia].
    Hamano A; Shingaki S; Abe Y; Miyazaki K; Sekine R; Nakagawa Y; Tsukada N; Hattori Y; Suzuki K
    Rinsho Ketsueki; 2014 Apr; 55(4):428-35. PubMed ID: 24850453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal dynamics and clinical implications of postremission clonal hematopoiesis in acute myeloid leukemia.
    Tanaka T; Morita K; Loghavi S; Wang F; Furudate K; Sasaki Y; Little L; Gumbs C; Matthews J; Daver N; Pemmaraju N; DiNardo CD; Sasaki K; Yilmaz M; Kadia TM; Ravandi F; Konopleva MY; Kantarjian HM; Champlin RE; Al-Atrash G; Garcia-Manero G; Wang SA; Futreal PA; Takahashi K
    Blood; 2021 Nov; 138(18):1733-1739. PubMed ID: 34115096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy-selected clonal hematopoiesis and its role in myeloid neoplasms.
    Jahn J; Diamond B; Hsu J; Montoya S; Totiger TM; Landgren O; Maura F; Taylor J
    Leuk Res; 2023 Mar; 126():107020. PubMed ID: 36696829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrum From Clonal Hematopoiesis to Myelodysplastic Neoplasm/Syndromes and Other Myeloid Neoplasms.
    Xie Z; Chen EC; Mendez LM; Komrokji R; Zeidan AM
    Cancer J; 2023 May-Jun 01; 29(3):130-137. PubMed ID: 37195768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.